Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

EYENOVIA, INC. (EYEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 8-K Investor presentation
Docs: "Eyenovia Acquires U.S. Commercial Rights to APP13007 from Formosa Pharmaceuticals",
"2024 2025 2026 2027 2028 2029"
05/11/2023 8-K Investor presentation, Quarterly results
Docs: "Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update",
"Forward-looking Statements Except for historical information, all the statements, expectations and assumptions contained in this presentation are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions, including estimated market opportunities for our product candidates and platform technology. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Ther..."
10/25/2021 8-K Investor presentation
Docs: "Eyenovia Announces Reclassification of MydCombi as Drug-Device Combination Product by FDA",
"2020 1 IMS, 2015 2"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy